- Home
- BWAY vs IIF Comparison
BWAY vs IIF Comparison
Compare BWAY & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- IIF
- Stock Information
- Founded
- BWAY 2003
- IIF 1993
- Country
- BWAY Israel
- IIF United States
- Employees
- BWAY N/A
- IIF N/A
- Industry
- BWAY Medical/Dental Instruments
- IIF Trusts Except Educational Religious and Charitable
- Sector
- BWAY Health Care
- IIF Finance
- Exchange
- BWAY Nasdaq
- IIF Nasdaq
- Market Cap
- BWAY 280.7M
- IIF 255.7M
- IPO Year
- BWAY 2019
- IIF N/A
- Fundamental
- Price
- BWAY $15.44
- IIF $26.56
- Analyst Decision
- BWAY Strong Buy
- IIF
- Analyst Count
- BWAY 2
- IIF 0
- Target Price
- BWAY $20.50
- IIF N/A
- AVG Volume (30 Days)
- BWAY 65.4K
- IIF 45.4K
- Earning Date
- BWAY 11-11-2025
- IIF 01-01-0001
- Dividend Yield
- BWAY N/A
- IIF 13.94%
- EPS Growth
- BWAY 213.09
- IIF N/A
- EPS
- BWAY 0.13
- IIF N/A
- Revenue
- BWAY $49,094,000.00
- IIF N/A
- Revenue This Year
- BWAY N/A
- IIF N/A
- Revenue Next Year
- BWAY N/A
- IIF N/A
- P/E Ratio
- BWAY $47.75
- IIF N/A
- Revenue Growth
- BWAY 27.08
- IIF N/A
- 52 Week Low
- BWAY $7.84
- IIF $18.95
- 52 Week High
- BWAY $17.92
- IIF $24.41
- Technical
- Relative Strength Index (RSI)
- BWAY 48.93
- IIF 38.96
- Support Level
- BWAY $14.27
- IIF $26.62
- Resistance Level
- BWAY $15.56
- IIF $27.09
- Average True Range (ATR)
- BWAY 0.82
- IIF 0.30
- MACD
- BWAY -0.10
- IIF -0.04
- Stochastic Oscillator
- BWAY 51.44
- IIF 8.33
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.